Skip to content

DR. YVES KOCKAERTS

Active
Private limited companyfounded 2010active for 16 yearsZandstraat 55, 3590 Diepenbeek, BelgiumKBO/BCE: BE 0828.634.772
Summary

DR. YVES KOCKAERTS has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.3m and a net result of €199,988. Equity has been growing by about 20% per year since 2018. Its solvency ranks better than 92% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 20-08-2010 Normal situation
Activity
Specialist medical practice NACE 86220and 1 other
Establishment unit
2.328.684.245 3600 Genk, since 20-08-2010
Financial year end
31 December
Peppol
Reachable since 09-12-2025

Board and ownership

Board

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€365,254
▲ 60.2%
Turnover
≈ €560,000
estimated
Profit
€199,988
▲ 6.5%
Equity
€1.3m
▲ 18.1%
Total assets
€1.4m
▲ 20.3%
  • 2025 accounts filed 56 days after the deadline
Score breakdownraises riskLast filed accounts filed 56 days late; 1 of the last 3 accounts latelowers riskSector: Human health activities (NACE 86)Equity €1.3m (95.0% of total assets)Size: total assets €1.4mShow the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 51% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 95.0% of total assets
Liquidity 66-34
short-term debt 5.0% · cash 12.9%
Profitability 71-18
return on assets 14.6%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026highest value 11-2026: < 0.1%● unchanged vs 10-2026highest value
Credit of up to €120,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 20.11 (20.71 in 2024), above the usual 1.5. Short-term debt is 5% and cash 12.9% of total assets. 5% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 46% on liquidity, 15% on profitability and 62% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Last filed accounts filed 56 days late; 1 of the last 3 accounts late
NBB · filings
lowers risk · Equity €1.3m (95.0% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €1.4m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · 2025 accounts filed 56 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-09-2026, 56 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
56 days late
2024
15 days early
2023
29 days late
2022
13 days early
2021
11 days early
2020
12 days late
2019
on the day
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 8 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 20 July (4 of the last 5 accounts filed within 41 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: More equity than 95% of companies in human healthsector median €124,659 · 20,702 companies €1.3m View
  • Positive: 8 profitable years in a rowprofit 2025: €199,988 8 years View

Recent changes

  1. · Gazette deed Resignation: KOCKAERTS Yves (director)Reappointment: KOCKAERTS Yves (director)
  2. · Gazette deed Incorporation
All 15 events

Comparable companies

These companies have the same main activity as DR. YVES KOCKAERTS: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.3m and €1.5m, founded between 2009 and 2012.

CompanyTotal assetsGross margin
DR. YVES KOCKAERTS Diepenbeek€1.4m€0.4m
Dokter Dirckx Veerle Lommel€1.3m€0.4m
DOKTER NEVEN ENRICO Dilsen-Stokkem€1.5m€0.4m
LANDENNE Sophie MAXILLO-FACIALE Namur€1.4m€0.4m
AUDE COUPE Namur€1.4m€0.4m
Pheidias Gent€1.3m€0.4m
DR. JACOBS RUBEN - ORTHOPEDIE Heist-op-den-Berg€1.4m€0.4m
Full comparison

Key facts about DR. YVES KOCKAERTS

What is the company number of DR. YVES KOCKAERTS?
The company number of DR. YVES KOCKAERTS is 0828.634.772. The VAT number is the same number with BE in front: BE 0828.634.772.
Where is DR. YVES KOCKAERTS based?
The registered office is at Zandstraat 55, 3590 Diepenbeek.Company details
What does DR. YVES KOCKAERTS do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. YVES KOCKAERTS?
The legal form of DR. YVES KOCKAERTS is Private limited company (BV).
When was DR. YVES KOCKAERTS founded?
DR. YVES KOCKAERTS was founded on 20-08-2010.
Is DR. YVES KOCKAERTS still active?
Yes, DR. YVES KOCKAERTS is an active enterprise in the KBO register.
What is the turnover of DR. YVES KOCKAERTS?
The turnover in financial year 2025 is ≈ €560,000. This figure is estimated from the gross margin of €365,254 and 36 comparable companies (NACE 862). It probably lies between €510,000 and €710,000.Financials
Is DR. YVES KOCKAERTS profitable?
In financial year 2025, DR. YVES KOCKAERTS made a profit of €199,988.
Where can I find the annual accounts of DR. YVES KOCKAERTS?
DR. YVES KOCKAERTS filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. YVES KOCKAERTS due?
DR. YVES KOCKAERTS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.